Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
NCT00004833
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
170
Enrollment
OTHER
Sponsor class
Conditions
Guillain-Barre Syndrome
Interventions
DRUG:
Immune globulin
Sponsor
Emory University